Josef S Smolen

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update

Josef S Smolen, Robert Landewé, J. W. J. Bijlsma et al. · Annals of the Rheumatic Diseases · 2020 · 2.8K citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +15

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update

Josef S Smolen, Robert Landewé, Sytske Anne Bergstra et al. · Annals of the Rheumatic Diseases · 2022 · 1.8K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Dickkopf-1 is a master regulator of joint remodeling

Danielle Diarra, Marina Stolina, Karin Polzer et al. · Nature Medicine · 2007 · 1.3K citations

Medicine, Molecular Genetics, Orthopedic Surgery +4

Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: A randomized, controlled trial

E. William St. Clair, Désirée van der Heijde, Josef S Smolen et al. · Arthritis & Rheumatism · 2004 · 1.2K citations

Medicine, Pharmacology, Pharmacotherapy +12

American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials

David T. Felson, Josef S Smolen, George A. Wells et al. · Arthritis & Rheumatism · 2011 · 1K citations · Full text

Medicine, Clinical Sciences, Autoimmunity +13